600 related articles for article (PubMed ID: 10500434)
21. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
23. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
25. [Extrahepatic manifestations in hepatitis C. Are they overlooked?].
Kristiansen MG; Florholmen J
Tidsskr Nor Laegeforen; 2001 Feb; 121(4):446-9. PubMed ID: 11255860
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
27. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
[TBL] [Abstract][Full Text] [Related]
28. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
29. [Extrahepatic manifestations related to hepatitis C virus].
Opolon P; Lunel F
Pathol Biol (Paris); 1995 Oct; 43(8):709-15. PubMed ID: 8745593
[TBL] [Abstract][Full Text] [Related]
30. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
31. [Extrahepatic manifestations of hepatitis C virus infection].
Loustaud-Ratti V; Lunel F
Rev Prat; 2000 May; 50(10):1089-93. PubMed ID: 10905094
[TBL] [Abstract][Full Text] [Related]
32. Type 2 autoimmune hepatitis and hepatitis C viraemia.
Leri O; Paparo Barbaro S; Sinopoli MT; Marcelli V; De Rosa FG; De Luca D
Riv Eur Sci Med Farmacol; 1996; 18(1):3-6. PubMed ID: 8766775
[TBL] [Abstract][Full Text] [Related]
33. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
34. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
35. [Skin diseases and hepatitis virus C infection].
Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z
Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
[TBL] [Abstract][Full Text] [Related]
37. Role of autoimmunity in nonviral chronic liver disease.
Amarapurkar DN; Amarapurkar AD
J Assoc Physicians India; 2000 Nov; 48(11):1064-9. PubMed ID: 11310382
[TBL] [Abstract][Full Text] [Related]
38. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune reactions in HBV and HCV.
Michalska Z; Stalke P; Witczak-Malinowska K; Lakomy EA; Sikorska K; Radowska D; Stolarczyk J; Trocha H
Med Sci Monit; 2001 May; 7 Suppl 1():175-80. PubMed ID: 12211715
[TBL] [Abstract][Full Text] [Related]
40. Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infection.
Adeyemi OM; Attar B; Jensen D; Ghaoui R; Cotler SJ
HIV Med; 2005 Nov; 6(6):371-4. PubMed ID: 16268816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
